PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma

by Sagun Parakh, Sagun Parakh, Sagun Parakh, Ashan Musafer, Ashan Musafer, Sabrina Paessler, Tom Witkowski, Tom Witkowski, Connie S. N. Li Wai Suen, Candani S. A. Tutuka, Matteo S. Carlino, Matteo S. Carlino, Alexander M. Menzies, Alexander M. Menzies, Richard A. Scolyer, Richard A. Scolyer, Richard A. Scolyer, Jonathan Cebon, Jonathan Cebon, Jonathan Cebon, Alexander Dobrovic, Alexander Dobrovic, Georgina V. Long, Georgina V. Long, Georgina V. Long, Oliver Klein, Oliver Klein, Andreas Behren, Andreas Behren, Andreas Behren
Published 2021-06-01

Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)

by Elizabeth M. Swisher, Tanya T. Kwan, Amit M. Oza, Anna V. Tinker, Isabelle Ray-Coquard, Ana Oaknin, Robert L. Coleman, Carol Aghajanian, Gottfried E. Konecny, David M. O’Malley, Alexandra Leary, Diane Provencher, Stephen Welch, Lee-may Chen, Andrea E. Wahner Hendrickson, Ling Ma, Prafull Ghatage, Rebecca S. Kristeleit, Oliver Dorigo, Ashan Musafer, Scott H. Kaufmann, Julia A. Elvin, Douglas I. Lin, Setsuko K. Chambers, Erin Dominy, Lan-Thanh Vo, Sandra Goble, Lara Maloney, Heidi Giordano, Thomas Harding, Alexander Dobrovic, Clare L. Scott, Kevin K. Lin, Iain A. McNeish
Published 2021-05-01